Aytu BioPharma, Inc.
$2.58
▲
1.52%
2026-04-21 05:32:00
aytubio.com
NCM: AYTU
Explore Aytu BioPharma, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$27.69 M
Current Price
$2.58
52W High / Low
$3.06 / $0.98
Stock P/E
—
Book Value
$1.32
Dividend Yield
—
ROCE
4.15%
ROE
-1.09%
Face Value
—
EPS
$-3.44
Exp Qtr EPS
—
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
82
Beta
0.28
Debt / Equity
155.63
Current Ratio
1.16
Quick Ratio
1.07
Forward P/E
15
Price / Sales
0.44
Enterprise Value
$19.45 M
EV / EBITDA
4.83
EV / Revenue
0.31
Rating
None
Target Price
$9.67
EPS Forecast (FY)
—
Pros
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Prestige Consumer Healthcare Inc. | $58.68 | 14.89 | $2.78 B | — | 10.6% | 10.31% | $89.37 / $51.24 | $38.66 |
| 2. | Ironwood Pharmaceuticals, Inc. | $4.42 | 29.94 | $719.09 M | — | 76.78% | -8.53% | $5.78 / $0.53 | $-1.61 |
| 3. | Cardiol Therapeutics Inc. | $1.51 | — | $230.46 M | — | -162.05% | -1.59% | $2.17 / $1.23 | $0.08 |
| 4. | IM Cannabis Corp. | $0.41 | — | $3.13 M | — | 510.44% | -516.26% | $9.7 / $1.75 | $-0.45 |
| 5. | Collegium Pharmaceutical, Inc. | $34.31 | 17.33 | $1.09 B | — | 14.67% | 23.7% | $50.79 / $25.86 | $9.51 |
| 6. | Universe Pharmaceuticals INC | $3.32 | — | $1.9 M | — | -5.19% | -7.23% | $11 / $2 | $99.64 |
| 7. | China SXT Pharmaceuticals, Inc. | $2.06 | — | $1.97 M | — | -17.13% | -50.3% | $1,046.98 / $1.25 | $26.16 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 15.16 M | 13.89 M | 15.13 M | 18.45 M | 16.22 M | — |
| Operating Profit | -1.97 M | -1.5 M | 0.64 M | 2.42 M | -0.38 M | — |
| Net Profit | -10.58 M | 1.97 M | -19.82 M | 3.99 M | 0.79 M | — |
| EPS in Rs | -0.99 | 0.18 | -1.85 | 0.37 | 0.07 | -0.15 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 66.38 M | 65.18 M | 107.4 M | 96.67 M |
| Operating Profit | 2.54 M | 0.56 M | -12.33 M | -36.1 M |
| Net Profit | -13.56 M | -15.84 M | -17.05 M | -108.78 M |
| EPS in Rs | -1.26 | -1.48 | -1.59 | -10.13 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 124.18 M | 118.09 M | 136.46 M | 137.62 M |
| Total Liabilities | 105.21 M | 90.38 M | 97.11 M | 93.31 M |
| Equity | 18.97 M | 27.72 M | 39.36 M | 44.31 M |
| Current Assets | 79.18 M | 61.89 M | 71.08 M | 59.93 M |
| Current Liabilities | 63.06 M | 62.23 M | 69.02 M | 64.44 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | -1.94 M | -1.39 M | -5.13 M | -28.82 M |
| Investing CF | -2.56 M | -0.33 M | -0.12 M | -3.25 M |
| Financing CF | 15.44 M | -1.26 M | 8.87 M | 1.53 M |
| Free CF | -5.17 M | -1.72 M | -5.13 M | -28.82 M |
| Capex | -3.23 M | -0.33 M | — | — |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | -39.31% | 11.1% | — | — |
| Earnings Growth % | 7.08% | 84.33% | — | — |
| Profit Margin % | -24.31% | -15.88% | -112.53% | — |
| Operating Margin % | 0.87% | -11.48% | -37.35% | — |
| Gross Margin % | 75.26% | 62.04% | 54.08% | — |
| EBITDA Margin % | 2.16% | -3.05% | -26.85% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
| Date | Split |
|---|---|
| 2023-01-06 | 1:0.05 |